<SEC-DOCUMENT>0001520138-18-000037.txt : 20180321
<SEC-HEADER>0001520138-18-000037.hdr.sgml : 20180321
<ACCEPTANCE-DATETIME>20180321130806
ACCESSION NUMBER:		0001520138-18-000037
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180320
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180321
DATE AS OF CHANGE:		20180321

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOVIE INC.
		CENTRAL INDEX KEY:			0001580149
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				462510769
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-55292
		FILM NUMBER:		18704044

	BUSINESS ADDRESS:	
		STREET 1:		100 CUMMINGS CENTER,
		STREET 2:		SUITE 247-C
		CITY:			BEVERLY
		STATE:			MA
		ZIP:			01915
		BUSINESS PHONE:		312-283-5793

	MAIL ADDRESS:	
		STREET 1:		100 CUMMINGS CENTER,
		STREET 2:		SUITE 247-C
		CITY:			BEVERLY
		STATE:			MA
		ZIP:			01915

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NANOANTIBIOTICS, INC.
		DATE OF NAME CHANGE:	20130625
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bivi-20180320_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 227.4pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 227.4pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant to Section&nbsp;13 or 15(d)</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>of the&nbsp;Securities Exchange Act
of 1934.</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>Date of Report: March 20, 2018</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Date of earliest event reported)</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 227.4pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 24pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>BioVie Inc.</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Exact name of registrant as specified
in its charter)</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 227.4pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 3pt 0 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
<TR>
    <TD STYLE="width: 32%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 32%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 32%; line-height: 115%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nevada</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>333-190635</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>46-2510769</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>(State or other jurisdiction</B></P>
        <P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>of incorporation)</B></P></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>(Commission</B></P>
        <P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>File Number)</B></P></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>(IRS Employer</B></P>
        <P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center"><B>Identification Number)</B></P></TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 2.8pt; text-align: center; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>100 Cummings Center, Suite 247-C, Beverly, MA</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>01915</B></FONT></TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 2.8pt; text-align: center; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>(Address of principal executive offices)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>(312) 283-5793</B></P>

<P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Registrant&#8217;s telephone number,
including area code)</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>NanoAntibiotics, Inc.</B></P>

<P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Former Name or Former Address, if
changed since last report)</B></P>

<P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"></P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 227.4pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 6pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 96%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 6pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 96%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 6pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 96%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 6pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 96%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-bottom: Black 1pt solid"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 4.01 Changes in Registrant&#8217;s Certifying Accountant.</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 23pt; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 23pt; text-align: justify">On March 9, 2018, BioVie Inc. (&quot;<B>BioVie</B>&quot;
or &ldquo;<B>Company</B>&rdquo;) filed a Form 8-K pertaining to its change in accounting firms. In compliance with Item 304(a)(3)
of Regulation S-K, BioVie submits, as an attachment hereto, a letter from its former accounting firm, stating its agreement with
statements made by BioVie in that earlier filing. That letter was unavailable at the time BioVie made its March 9 Form 8-K filing.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 23pt"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 9.01 Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">(d) Exhibits</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Exhibit Number</B></FONT></TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 66%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 4.5pt; text-align: center; vertical-align: middle"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle"><FONT STYLE="font-size: 10pt"><A HREF="bivi-20180320_8kex99z1.htm">Letter from Weinberg and Baer, dated March 20, 2018</A></FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 23pt; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 23pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-&nbsp;</FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 10pt"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    March 21, 2018</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; padding-right: 2.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOVIE INC.</B></FONT></TD>
    <TD STYLE="padding-bottom: 0pt">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="line-height: 100%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 100%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 100%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 100%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0pt">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; border-bottom: black 0.75pt solid"><I>/s/ Jonathan Adams</I></P></TD>
    <TD STYLE="padding-bottom: 0pt">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jonathan Adams</FONT></TD>
    <TD STYLE="padding-bottom: 0pt">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="padding-bottom: 0pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding-bottom: 10pt">&nbsp;</TD>
    <TD COLSPAN="9" STYLE="line-height: 115%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD COLSPAN="8" STYLE="vertical-align: top; padding-right: 0.8pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 21%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="width: 23%">&nbsp;</TD></TR>
</TABLE>
<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>bivi-20180320_8kex99z1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Weinberg &amp; Baer LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">115 Sudbrook Lane, Baltimore, MD 21208</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Phone (410) 702-5660</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">March 20, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">U.S. Securities &amp; Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Washington, DC 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dear Commissioners:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>RE: FORM 8-K FILING REGARDING CHANGE IN ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have reviewed the disclosure contained in the Form 8-K filing
made by BioVie Inc. on March 9, 2018 pertaining to its change of accountants. We agree with the statements made in that filing
regarding Item 304 of Regulation S-K (&#8220;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Respectfully yours,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="image_001.gif" ALT="" STYLE="height: 59px; width: 288px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Weinberg &amp; Baer LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
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ME(V-C9^?GYN;FY>7EYB8F(J*BHZ.CH2$A)V=G8.#@XF)B8:&AH^/CXN+BX"
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M&Q.<X>Y$=SVQQ#SN>.-& 0V\ 0TZX)SLTC?W%/#&L@C==\P 9ES+T#CYP+$
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MDHX?;. &^*A+!@GB#60<  = L( \^)9!O*PN;:I;2P:/YQ#Q.*$.^5"=-^P
M@09\0W7]<.%#_^:AAAGD@V_>@H0#B,$WR D$;4[4$SM&H8$16& ,]+(7&X0
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M"/F0#I$P =R0 &[@55KQ#;]@ TI !$;@ "C  @90 5TP!T.  @T@!L'@#C,
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M, CY<1?B64^&1@^NQA9F(17V_S)R!#$J_S0^HS0JU=1K"J$'#  %KK0.J/
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" #L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
